Beyond Air Management

Management criteria checks 2/4

Beyond Air's CEO is Steve Lisi, appointed in Jun 2017, has a tenure of 6.92 years. total yearly compensation is $6.88M, comprised of 9.5% salary and 90.5% bonuses, including company stock and options. directly owns 3.25% of the company’s shares, worth $1.83M. The average tenure of the management team and the board of directors is 2.7 years and 6.8 years respectively.

Key information

Steve Lisi

Chief executive officer

US$6.9m

Total compensation

CEO salary percentage9.5%
CEO tenure6.9yrs
CEO ownership3.2%
Management average tenure2.7yrs
Board average tenure6.8yrs

Recent management updates

Recent updates

We're Keeping An Eye On Beyond Air's (NASDAQ:XAIR) Cash Burn Rate

Apr 05
We're Keeping An Eye On Beyond Air's (NASDAQ:XAIR) Cash Burn Rate

Will Beyond Air (NASDAQ:XAIR) Spend Its Cash Wisely?

Dec 14
Will Beyond Air (NASDAQ:XAIR) Spend Its Cash Wisely?

Beyond Air presents pilot at-home study data; stock earlier snaps 7-day losing streak

Oct 17

Beyond Air: Bottom Line Fundamentals Keep Buyers At Bay

Sep 08

Beyond Air affiliate Beyond Cancer doses patient in phase 1 study of ultra-high concentration nitric oxide therapy

Aug 23

Beyond Air reaches six-month high after $2.3M insider transactions

Jul 06

Companies Like Beyond Air (NASDAQ:XAIR) Are In A Position To Invest In Growth

May 02
Companies Like Beyond Air (NASDAQ:XAIR) Are In A Position To Invest In Growth

Here's Why Shareholders May Want To Be Cautious With Increasing Beyond Air, Inc.'s (NASDAQ:XAIR) CEO Pay Packet

Feb 25
Here's Why Shareholders May Want To Be Cautious With Increasing Beyond Air, Inc.'s (NASDAQ:XAIR) CEO Pay Packet

Beyond Air: Follow The CEO And Buy The Dip

Dec 16

CEO Compensation Analysis

How has Steve Lisi's remuneration changed compared to Beyond Air's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-US$67m

Sep 30 2023n/an/a

-US$63m

Jun 30 2023n/an/a

-US$59m

Mar 31 2023US$7mUS$650k

-US$56m

Dec 31 2022n/an/a

-US$56m

Sep 30 2022n/an/a

-US$51m

Jun 30 2022n/an/a

-US$47m

Mar 31 2022US$6mUS$450k

-US$43m

Dec 31 2021n/an/a

-US$28m

Sep 30 2021n/an/a

-US$26m

Jun 30 2021n/an/a

-US$23m

Mar 31 2021US$2mUS$450k

-US$23m

Dec 31 2020n/an/a

-US$23m

Sep 30 2020n/an/a

-US$22m

Jun 30 2020n/an/a

-US$21m

Mar 31 2020US$1mUS$450k

-US$20m

Dec 31 2019n/an/a

-US$15m

Sep 30 2019n/an/a

-US$13m

Jun 30 2019n/an/a

-US$11m

Mar 31 2019US$3mUS$450k

-US$7m

Dec 31 2018n/an/a

-US$5m

Sep 30 2018n/an/a

-US$5m

Jun 30 2018n/an/a

-US$10m

Mar 31 2018US$537kUS$130k

-US$11m

Dec 31 2017US$2mUS$163k

-US$18m

Compensation vs Market: Steve's total compensation ($USD6.88M) is above average for companies of similar size in the US market ($USD667.63K).

Compensation vs Earnings: Steve's compensation has increased whilst the company is unprofitable.


CEO

Steve Lisi (52 yo)

6.9yrs

Tenure

US$6,876,550

Compensation

Mr. Steven Adam Lisi, also known as Steve, has been the Chief Executive Officer of Beyond Air, Inc. (formerly known as AIT Therapeutics, Inc.) since June 14, 2017. Mr. Lisi serves as Chief Executive Office...


Leadership Team

NamePositionTenureCompensationOwnership
Steven Lisi
CEO & Chairman of the Board6.9yrsUS$6.88m3.25%
$ 1.8m
Amir Avniel
Co-Founder13.3yrsUS$3.20m0.95%
$ 538.8k
Michael Gaul
Chief Operating Officer1.8yrsUS$1.13m0.14%
$ 80.1k
Douglas Larson
CFO, Principal Financial Officer & Principal Accounting Officer2.7yrsUS$1.13m0.040%
$ 22.8k
Edward Barger
Head of Investor Relationsno datano datano data
Kori-Ann Taylor
Head of Marketing3yrsno datano data
Andrew Colin
Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board2.4yrsno datano data
Jeff Myers
Chief Medical Officer1.2yrsno data0.10%
$ 57.3k
Adam Newman
Corporate Secretaryno dataUS$643.57kno data

2.7yrs

Average Tenure

52yo

Average Age

Experienced Management: XAIR's management team is considered experienced (2.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Steven Lisi
CEO & Chairman of the Board7.3yrsUS$6.88m3.25%
$ 1.8m
Amir Avniel
Co-Founder13.3yrsUS$3.20m0.95%
$ 538.8k
Andrew Colin
Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board11.3yrsno datano data
Yoori Lee
Independent Director6.3yrsUS$199.20k0.028%
$ 15.6k
Robert Carey
Independent Director5.3yrsUS$324.60k6.49%
$ 3.7m
Ron Bentsur
Independent Director7.3yrsUS$199.20k0.32%
$ 178.0k
William Forbes
Independent Director5.8yrsUS$199.20k0.032%
$ 18.3k
Yossef Av-Gay
Member of Scientific Advisory Board6.3yrsUS$75.00kno data
David Greenberg
Member of Scientific Advisory Boardno datano datano data
Richard Malley
Member of Scientific Advisory Boardno datano datano data
Erick Lucera
Independent Director6.8yrsUS$199.20k0.0095%
$ 5.3k
Hannah Blau
Member of Scientific Advisory Boardno datano datano data

6.8yrs

Average Tenure

57yo

Average Age

Experienced Board: XAIR's board of directors are considered experienced (6.8 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.